Autoimmune Hepatitis: Pathogenesis, Diagnosis and Treatment
Author:
- 1 January 1998
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 33 (225) , 66-69
Abstract
Autoimmune hepatitis (AIH) is a chronic necro-inflammatory disease of the liver. Early recognition is important in order to prevent the development of cirrhosis. This review discusses recent developments in the fields of diagnosis, pathophysiology and management of AIH. Relevant manuscripts were identified using an electronic database, and by hand search of a personal library. Description of new auto-antibodies, and formulation of diagnostic criteria and a scoring system by an international panel constitute important advances that may help diagnosis of the disease at an early stage. While a satisfying animal model of the disease is lacking, clinical observations have led to the formulation of a pathophysiological model. Current treatment has a failure rate of about 13%, and is unable to induce a permanent remission in most patients. New immunosuppressive agents (cyclosporine, tacrolimus and mycophenolate mofetil) appear promising, and should be evaluated in controlled trials.Keywords
This publication has 9 references indexed in Scilit:
- Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individualsThe Lancet, 1995
- Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitisGastroenterology, 1993
- Meeting report: International autoimmune hepatitis groupHepatology, 1993
- Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseasesHepatology, 1993
- LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.Journal of Clinical Investigation, 1991
- Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individualsThe Lancet, 1991
- ANTIBODIES TO LIVER-SPECIFIC PROTEIN PREDICT OUTCOME OF TREATMENT WITHDRAWAL IN AUTOIMMUNE CHRONIC ACTIVE HEPATITISThe Lancet, 1984
- Natural History, Clinical Features, and Treatment of Autoimmune HepatitisSeminars in Liver Disease, 1984
- INADEQUATE ANTIBODY RESPONSE TO HBAg OR SUPPRESSOR T-CELL DEFECT IN DEVELOPMENT OF ACTIVE CHRONIC HEPATITISThe Lancet, 1974